As per study, risk of colorectal cancer remains despite modern treatment for ulcerative colitis


Patients suffering from the inflammatory bowel disease ulcerative colitis have a increased risk of dying from colorectal cancer, despite modern therapeutics, even though the risk has decreased in recent years. This is as per the new study advertised in the scientific journal The Lancet by a team of Swedish and Danish researchers.

Prior research has demonstrated that patients with ulcerative colitis have an elevated risk of colorectal cancer. Screening suggestions are therefore in place for this patient group. But to what extent have novel therapeutic methods assisted in reduction of this risk? This much-
heated question has now found new answers.

A large study enrolling 96,000 patients diagnosed with ulcerative colitis between the years 1969 and 2017 has now demonstrated that these patients run a higher risk of developing and dying of colorectal cancer.

As stated by Ola Olén, senior researcher at the Department of Medicine in Solna at Karolinska Institute in Sweden that the risk of colorectal cancer has declined substantially over the past 30 years, but in spite of this patients who have had access to modern treatments for ulcerative colitis and screening for colorectal cancer still have a vitally elevated risk.